Angioarrestin(hARP1)C端FD区的克隆、表达及其免疫活性鉴定

Angioarrestin是一种具有潜在应用价值的肿瘤血管形成抑制因子.利用DNA重组法构建了angioarrestinC端hFDcDNA和麦芽糖结合蛋白(MBP)重组原核表达质粒pMAL-C2-hFD.将重组质粒转入大肠杆菌E.coliBL21(DE3),经0.3mmol/LIPTG在37℃条件下诱导表达4h,SDS-PAGE检测,融合蛋白表达量约占细菌总蛋白的20%.Western印迹证实,目的蛋白N端带有MBP标签.取表达上清纯化、透析、浓缩并冻干,以此为抗原免疫Balb/c小鼠制备多克隆抗体.此多抗可以与pET-22b( )表达系统获得的hFD重组蛋白发生良好的抗原抗体反应,ELISA检测多抗效价达1∶10240.实验证明:通过基因重组可获得angioarrestinC端hFD在大肠杆菌中的高效表达蛋白,且该蛋白具有较高的免疫活性.以此为抗原制备的抗angioarrestin多克隆抗体为深入研究angioarrestin提供了材料.     

Angioarrestin(hARPl)C端FD区的克隆、表达及其免疫活性鉴定

 Angioarrestin是一种具有潜在应用价值的肿瘤血管形成抑制因子.利用DNA重组法构建了angioarrestin C端 hFD cDNA 和麦芽糖结合蛋白(MBP)重组原核表达质粒 pMAL-C2-hFD.将重组质粒转入大肠杆菌E.coli BL21（DE3）,经0.3 mmol/LIPTG 在37℃条件下诱导表达4h,SDS-PAGE 检测,融合蛋白表达量约占细菌总蛋白的20%.Western印迹证实,目的蛋白N端带有MBP标签.取表达上清纯化、透析、浓缩并冻干,以此为抗原免疫Balb/c小鼠制备多克隆抗体.此多抗可以与pET 22b（+）表达系统获得的 hFD重组蛋白发生良好的抗原抗体反应,ELISA检测多抗效价达1∶10240.实验证明：通过基因重组可获得angioarrestin C端hFD在大肠杆菌中的高效表达蛋白,且该蛋白具有较高的免疫活性.以此为抗原制备的抗angioarrestin多克隆抗体为深入研究angioarrestin提供了材料.     

单增李斯特菌InternalinA的表达、纯化及多克隆抗体的制备

【目的】克隆表达单增李斯特菌膜表面蛋白InternalinA(InlA),经免疫家兔获得多克隆抗体,为建立其免疫磁珠富集快速检测方法奠定基础。【方法】利用生物软件设计单增李斯特菌inlA基因的引物,通过PCR扩增出inlA基因,并将其克隆至pET28a()原核表达载体,转化大肠杆菌BL21进行优化表达。镍柱纯化表达产物,质谱鉴定重组蛋白,ELISA分析其免疫原性。免疫家兔,制备其多克隆抗体。间接ELISA检测多抗的效价及交叉性,免疫荧光分析多抗与单增李斯特菌菌体结合的特异性。【结果】成功表达了InlA蛋白,融合表达产物分子量约为92 kD,质谱鉴定其为InlA蛋白;免疫家兔获得的抗血清效价为1:100 000,除与金黄色葡萄球菌约20%的交叉外,与副溶血弧菌等其它病源菌均无交叉;免疫荧光证实该多抗特异性结合于单增李斯特菌膜表面,与同种属的威尔斯李斯特菌不结合。【结论】成功制备了单增李斯特菌特异性的兔多克隆抗体,为单增李斯特菌免疫磁珠富集快速检测方法的建立奠定了基础。     

重组SCIRR39多克隆抗体的制备及检测

目的：在大肠杆菌中表达大鼠脊髓损伤与修复蛋白39（SCIRR39）的C端抗原表位,并制备其多克隆抗体。方法：从大鼠脊髓全横断损伤脊髓cDNA中扩增1386bp的Scirr39基因编码框,亚克隆该基因编码蛋白C端359～461位氨基酸残基的DNA片段,插入表达载体,转化大肠杆菌BL21（DE3）,IPTG诱导表达,SDS-PAGE分析表达情况,切胶纯化目的蛋白;利用多克隆抗体制备技术,制备重组SCIRR39蛋白的多克隆抗体;用ELISA方法检测抗体效价,Western印迹检测抗体的特异性。结果：SCIRR39蛋白C端抗原表位与GST的融合蛋白在大肠杆菌中以可溶形式高表达,相对分子质量为37．9×103;获得抗SCIRR39蛋白C端抗原表位的兔抗血清,其效价达到1：104;Western印迹显示多克隆抗体能特异识别重组SCIRR39蛋白的C端抗原表位。结论：在原核系统中表达纯化了重组SCIRR39抗原表位蛋白,制备的重组蛋白多克隆抗体将用于检测SCIRR39在脊髓损伤过程中的表达变化。     

GST-Ccd1融合蛋白的表达、纯化及多克隆抗体制备

目的：利用大肠杆菌DH5α表达GST—Ccd1融合蛋白,并用亲和层析分离纯化,进行动物免疫制备多克隆抗体。方法：利用本室构建好的pGEX-5X-1-Ccd1-N原核表达重组质粒,转化大肠杆菌DH5α,经IPTG诱导表达,在大肠杆菌表达系统中获得可溶性表达。经谷胱甘肽Sepharose 4B介质填充的层析柱分离纯化蛋白,制备抗原免疫动物,得到Ccd1的兔源多克隆抗体。结果：ELISA结果显示血清抗体效价可以达到1∶40 000。免疫组化分析表明自制的抗体能特异性与Ccd1蛋白相互作用,可以用于实验分析。结论：制备了效价高特异性良好的抗Ccd1多克隆抗体,经实验验证获得的抗体能够满足针对Ccd1的免疫印迹和免疫组化检测的实验要求,为今后深入研究Ccd1表达的组织分布、细胞内定位及其生物学功能提供了有用的实验工具。     

抗谷胱甘肽S转移酶多克隆抗体的制备及特异性鉴定

目的:制备谷胱甘肽S转移酶(GST)的兔多抗,并鉴定该抗体的特异性。方法:用纯化的GST标签蛋白(纯度>98%)免疫新西兰大白兔,获得GST的兔抗血清,并经HiTrap rProtein A柱纯化获得高效价高特异性的抗体;用间接ELISA法检测抗体效价,Western印迹检测抗体的特异性,并与商业化抗体进行对比。结果:通过免疫法得到了GST的兔多克隆抗体血清,抗体效价达1∶1×106,经rProtein A柱纯化后获得了高效价高特异性的抗体,其高效高特异性已达商业化抗体水平。结论:获得了GST的高效价高特异性的兔多克隆抗体。     

Carboxin抗性基因(Cbx~R)原核表达及多克隆抗体的制备

[目的]克隆CbxR基因,进行原核表达,纯化CbxR基因蛋白并制备其多克隆抗体。[方法]CbxR基因克隆至原核表达载体p ET-28a(+),转化大肠杆菌BL21(DE3)诱导表达并纯化,Western blot鉴定分析。制备CbxR蛋白的兔源多克隆抗体,运用间接ELISA方法检测多抗效价,利用Western blot印记检测抗体特异性。[结果]成功获得CbxR基因,在大肠杆菌BL21(DE3)中诱导可大量表达,成功制备CbxR蛋白兔源多克隆抗体,效价为1∶64 000,经Western blot检测表明多克隆抗体特异性良好。[结论]多克隆抗体为CbxR检测及进一步研究CbxR基因功能奠定了基础。     

土拉弗朗西斯菌两种不同长度的外膜蛋白FopA抗原和抗体的制备

目的:根据外膜蛋白 FopA 的序列信息,建立土拉弗朗西斯菌 FopA蛋白全长(FopA-L)和部分(FopA-S)的特异性抗原的 BL21 表达系统,获得高活性的重组 FopA-L、FopA-S蛋白并制备相应的多克隆抗体,为土拉菌的监测、诊断和治疗提供依据。方法:通过 pET100 质粒构建FopA-L及FopA-S的表达载体,转化大肠杆菌BL21细胞并诱导表达FopA-L及FopA-S蛋白,螯合镍离子次氨基三乙酸(Ni-NTA)亲合层析纯化FopA蛋白,用重组蛋白免疫大耳白兔制备多克隆抗体,通过 ELISA、Western 印迹、胶体金免疫层析技术等方法进行检测。结果:构建了FopA-L及FopA-S的表达载体,获得相应的高表达目的蛋白 BL21 细胞株,用表达的蛋白为抗原成功制备了 FopA特异性的抗体,效价皆在1 ∶100000以上且特异性良好。结论:FopA-S与FopA-L两种抗原和相应抗体的制备为建立土拉菌快速检测方法奠定了基础。     

茶树咖啡碱合成酶基因原核表达、及其抗体制备与鉴定

克隆出茶树咖啡碱合成酶基因,对其进行原核表达,并制备TCS1抗体,旨在从蛋白水平研究茶树体内TCS1的表达情况。根据Gen Bank登陆的TCS1基因的全长c DNA序列,找出其完整的ORF(开放阅读框),从茶树叶片c DNA中克隆了TCS1基因的开放阅读框,连接到p GEX-4T-2表达载体,经IPTG诱导表达重组蛋白p GEX-4T-2-TCS1。进行体外酶活检测后,亲和层析纯化重组蛋白,作为抗原免疫家兔,制备TCS1多克隆抗体。用ELISA方法检测抗体效价,Western blot检测抗体的特异性。通过优化诱导条件,得出重组蛋白的最佳表达条件为:30℃、4 h。诱导后的总蛋白、可溶性蛋白与包涵体蛋白均出现一条明显的外源蛋白条带。抗体经ELISA检测,效价为1∶2 000,Western blot检测表明抗体具有相对较好的特异性。构建了TCS1原核表达质粒,同时成功制备了抗TCS1的多克隆抗体。     

化脓性链球菌溶血素O活性结构重组蛋白的制备

生物信息分析化脓性链球菌溶血素O(streptolysin O,Slo)蛋白结构表明,Slo蛋白除含有由461氨基酸残基组成的溶血活性结构域Thiol_cytolysin外,在N端还有一跨膜结构域。利用pET101-GENE蛋白表达系统,成功构建出表达具有Slo活性重组蛋白的重组子,采用镍柱亲和层析分离技术,纯化目的蛋白;纯化蛋白SDS-PAGE检测分析表明,重组蛋白与预测的溶血活性结构域的分子量相一致;溶血实验显示,纯化重组蛋白具有溶血活性。以纯化的重组蛋白为免疫原,对大鼠进行4次免疫,所获得免疫血清经 Elisa检测,抗Slo血清效价达到 1 ∶12 800;Western blot检测猪链球菌、马链球菌和化脓性链球菌中的链球菌溶血素结果显示,抗Slo多克隆抗体仅能与化脓性链球菌溶血素O发生反应,表明研究制备的化脓性链球菌溶血素O活性结构重组蛋白抗原具有较好的特异性,所制备的抗原Slo 可用于进一步开发抗链球菌溶血素O(ASO)试剂盒。     

Sp1 modulates ncOGT activity to alter target recognition and enhanced thermotolerance in E. coli

cDNAs encoding three isoforms of OGT (ncOGT, mOGT, and sOGT) were expressed in Escherichia coli in which the coexpression system of OGT with target substrates was established in vivo. No endogenous bacterial proteins were significantly O-GlcNAcylated by any type of OGT isoform while co-expressed p62 and Sp1 were strongly O-GlcNAcylated by ncOGT. These results suggest that most of bacterial proteins appear not to be recognized as right substrates by mammalian OGT whereas cytosolic environments may supply UDP-GlcNAc enough to proceed to O-GlcNAcylation in E. coli. Under these conditions, sOGT was auto-O-GlcNAcylated whereas ncOGT and mOGT were not. Importantly, we found that when Sp1 was coexpressed, ncOGT can O-GlcNAcylate not only Sp1 but also many bacterial proteins. Our findings suggest that Sp1 may modulate the capability of target recognition of ncOGT by which ncOGT can be led to newly recognize bacterial proteins as target substrates, finally generating the O-glyco-bacteria. Our results demonstrate that the O-glyco-bacteria showed enhanced thermal resistance to allow cell survival at a temperature as high as 52 °C.     

沙门菌毒力基因spvB的原核表达及其多克隆抗体的制备

目的:构建沙门菌毒力基因spvB的原核表达载体,诱导表达纯化SpvB蛋白并以其为抗原免疫小鼠,制备多克隆抗体。方法:利用生物信息学软件对SpvB进行分析,选取抗原性较高、易表达的氨基酸序列作为克隆序列,以携带spvB基因的鼠伤寒沙门菌为模板,PCR扩增目的片段后与原核表达载体pET28a(+)连接;将质粒pET28a-SpvB转化大肠埃希菌BL21(DE3)后诱导表达并纯化。目的蛋白免疫小鼠,制备抗SpvB多克隆抗体,Western blot检测抗体特异性。结果:成功构建spvB原核表达载体,经IPTG诱导结果显示,重组蛋白表达且主要存在于包涵体中,将纯化后的蛋白免疫小鼠Western blot检测血清中抗体与SpvB特异性结合。结论:获得具有免疫原性的SpvB蛋白及其多克隆抗体,为进一步研究该基因的功能奠定基础。     

Neutralizing chimeric mouse-human antibodies against Burkholderia pseudomallei protease: expression, purification and characterization

A recombinant Fab monoclonal antibody (Fab) C37, previously obtained by phage display and biopanning of a random antibody fragment library against Burkholderia pseudomallei protease, was expressed in different strains of Escherichia coli. E. coli strain HB2151 was deemed a more suitable host for Fab expression than other E. coli strains when grown in media supplemented with 0.2 % glycerol. The expressed Fab fragment was purified by affinity chromatography on a Protein G-Sepharose column, and the specificity of the recombinant Fab C37 towards B. pseudomallei protease was proven by Western blotting, enzyme-linked immunosorbent assay (ELISA) and by proteolytic activity neutralization. In addition, polyclonal antibodies against B. pseudomallei protease were produced in rabbits immunized with the protease. These were isolated from high titer serum by affinity chromatography on recombinant-Protein A-Sepharose. Purified polyclonal antibody specificity towards B. pseudomallei protease was proven by Western blotting and ELISA.     

类产碱假单胞菌杀虫蛋白的N端鉴定及抗体制备

The insecticidal protein from Pseudomonas pseudoaligenes was and exotoxin which had toxicity on locusts.In order to elucidate its molecular properties an amino acid sequence,the insecticidal protein was purified from the culture supernatant by ultrafiltration,ion\|exchange chromatography and gel filtration,and showed a single band on SDS\|PAGE.Analysis of the purified insecticidal protein dentified N\|terminal sequence of ten amino acid residues.Its polyclonal antibody was also obtained by immunizing rabb…     

猪FcγRIII的原核表达及多克隆抗体的制备

目的：构建猪FcγRIII 基因的原核表达载体,诱导表达重组蛋白,制备鼠抗猪 FcγRIII 抗血清。方法：从质粒pTG19-T-FcγRIII中用PCR方法克隆到编码完整猪FcγRIII蛋白分子的基因片段,将其插入到原核表达载体pET-32a中,构建了猪FcγRIII 原核表达载体pET-FcγRIII ,转化大肠杆菌BL21 (DE3) ,IPTG诱导蛋白表达,经尿素洗涤纯化后,以纯化后的融合蛋白FcγRIII-His 为抗原免疫小鼠,获得抗血清。Western blotting、ELISA 法鉴定获得的抗血清,ELISA 结果显示抗体效价为1∶16000,具有高度特异性,免疫印迹结果显示制备的多抗可以与重组猪FcγRIII蛋白特异性结合。结果：成功构建猪FcγRIII原核表达载体,纯化到融合蛋白FcγRIII-His,用纯化的融合蛋白免疫小鼠制备了多克隆抗体,Western blotting、ELISA 法证实多克隆抗体制备成功。结论：成功获得了猪 FcγRIII 多克隆抗体,为进一步研究猪FcγRIII 蛋白的功能奠定了基础。     

青杄FKBP12基因原核表达和多克隆抗体的制备

目的:制备青杄FKBP12基因的多克隆抗体,为进一步分析FKBP12的蛋白定位、表达等提供基础。方法:采用PCR方法扩增FKBP12基因得到其全长cDNA序列,并将其克隆至原核表达载体pET-48b中,转化入BL21菌株。经IPTG诱导,表达了分子量约为33kD的重组蛋白,SDS-PAGE和Western blotting检测鉴定表达产物。此蛋白经亲和纯化后,作为抗原注射新西兰兔,进行抗体制备。结果:成功获取了多克隆抗体,制备的FKBP12兔抗血清效价在1∶729 000以上,ELISA结果表明融合蛋白具良好的免疫原性。间接ELISA法检测纯化后抗体效价,表明纯化后抗FKBP蛋白兔多克隆抗体效价高,检测灵敏度为16ng/mL。结论:所制备的抗体能满足后续试验要求的效价值,为进一步研究提供基础。     

Prokaryotic expression and purification of HIV-1 Vif and hAPOBEC3G,preparation of polyclonal antibodies

To prepare HIV-1 Vif and hAPOBEC3G and to produce their antibodies, the full length gene fragment of HIV-1 Vif was amplified by PCR from a plasmid of HIV-1 NL4.3 cDNA, and the APOBEC3G gene was obtained by RT-PCR from the total RNA of H9 cells. The resulting DNA construct was cloned into a prokaryotic expression vector (pET-32a). Recombinant pET-vif and pET-APOBEC3G were expressed respectively in Eserichia coli BL21 (DE3) as an insoluble protein. The vector also contained a six-histidine tag at the C-terminus for convenient purification and detection. To express and purify the HIV-1 Vif and hAPOBEC3G in E. coli cells, the accuracy of inserted gene and specificity of proteins were detected by the two enzyme digestion method, SDS-PAGE, and Western blotting. Rabbits were then immunized by Vif or APOBEC3G protein and serum samples were tested by indirect ELISA to determine the level of antibodies. Immunoenzyme and immunofluorescence assays were performed to identify the specificity of polyclonal antibodies. The titer of the anti-Vif antibodies was 1:204800, and that of the anti-APOBEC3G antibodies was 1:102400. Thus the antibodies could detect the antigen expression in the cells, demonstrating that fusion proteins with high purity and their corresponding polyclonal antibodies with high titer and specificity were achieved.